共 94 条
- [1] Sarkar SD(2002)Comparison of (123)I and (131)I for whole-body imaging in thyroid cancer J Nucl Med 43 632-634
- [2] Kalapparambath TP(2007)Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma J Nucl Med 48 1043-1046
- [3] Palestro CJ(2001)Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer Clin Nucl Med 26 6-9
- [4] Silberstein EB(2008)Diagnostic whole-body scanning before radioiodine therapy for pulmonary metastases of differentiated thyroid cancer: predictive value and recommendations Clin Nucl Med 33 845-851
- [5] Mandel SJ(1997)Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma Thyroid 7 277-280
- [6] Shankar LK(1994)Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131 Thyroid 4 49-54
- [7] Benard F(1999)The usefulness of iodine-123 whole-body scans in evaluating thyroid carcinoma and metastases J Nucl Med Technol 27 279-281
- [8] Yamamoto A(2001)The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning Clin Endocrinol (Oxf) 55 515-521
- [9] Alavi A(2001)123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning J Clin Endocrinol Metab 86 5294-5300
- [10] Tachi Y(2002)I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours Clin Nucl Med 27 1-8